Your browser doesn't support javascript.
loading
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan.
Watanabe, Satoshi; Yoshioka, Hiroshige; Sakai, Hiroshi; Hotta, Katsuyuki; Takenoyama, Mitsuhiro; Yamada, Kazuhiko; Sugawara, Shunichi; Takiguchi, Yuichi; Hosomi, Yukio; Tomii, Keisuke; Niho, Seiji; Yamamoto, Nobuyuki; Nishio, Makoto; Ohe, Yuichiro; Kato, Terufumi; Takahashi, Toshiaki; Kamada, Ami; Suzukawa, Kazumi; Omori, Yukie; Enatsu, Sotaro; Nakagawa, Kazuhiko; Tamura, Tomohide.
Afiliação
  • Watanabe S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, 8050 Ikarashi 2-no-cho, Nishi-ku, Niigata, 950-2181, Japan.
  • Yoshioka H; Department of Respiratory Medicine, Kurashiki Central Hospital, 1 Chome-1-1 Miwa, Kurashiki, 710-8602, Japan.
  • Sakai H; Division of Thoracic Oncology, Saitama Cancer Center, 780 Komuro, Ina, Kitaadachi District, Saitama, 362-0806, Japan.
  • Hotta K; Department of Allergy and Respiratory Medicine, Center for Innovative Clinical Medicine, Okayama University Hospital, 2 Chome-5-1 Shikatacho, Kita, Okayama, 700-8558, Japan.
  • Takenoyama M; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, 3 Chome-1-1 Notame, Minami Ward, Fukuoka, 811-1395, Japan.
  • Yamada K; Department of Internal Medicine, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka Prefecture, 830-0011, Japan.
  • Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, 4-15 Hirosemachi, Aoba Ward, Sendai, Miyagi Prefecture, 980-0873, Japan.
  • Takiguchi Y; Department of Medical Oncology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
  • Hosomi Y; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3 Chome-18-22, Bunkyo-ku, Honkomagome, 113-0021, Tokyo, Japan.
  • Tomii K; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 2 Chome-1-1 Minatojima Minamimachi, Chuo Ward, Kobe, Hyogo Prefecture, 650-0047, Japan.
  • Niho S; Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba-ken, 277-8577, Japan.
  • Yamamoto N; Third Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama Prefecture, 641-8509, Japan.
  • Nishio M; Department of Thoracic Medical Oncology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.
  • Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Kato T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6 Chome-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama-shi, Kanagawa, 236-0051, Japan.
  • Takahashi T; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Kamada A; Medical Affairs, Eli Lilly Japan K.K., 7-1-5 Isogamidori, Chuo-Ku, Kobe, 651-0086, Japan.
  • Suzukawa K; Medical Affairs, Eli Lilly Japan K.K., 7-1-5 Isogamidori, Chuo-Ku, Kobe, 651-0086, Japan.
  • Omori Y; Medical Affairs, Eli Lilly Japan K.K., 7-1-5 Isogamidori, Chuo-Ku, Kobe, 651-0086, Japan.
  • Enatsu S; Medical Affairs, Eli Lilly Japan K.K., 7-1-5 Isogamidori, Chuo-Ku, Kobe, 651-0086, Japan.
  • Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, 3-4-1 Kowakae, Higashiosaka City, Osaka, 577-8502, Japan.
  • Tamura T; Thoracic Center, St. Luke's International Hospital, 9-1 Akashicho, Chuo-ku, Tokyo, 104-8560, Japan. Electronic address: tamuratomohide@gmail.com.
Lung Cancer ; 129: 55-62, 2019 03.
Article em En | MEDLINE | ID: mdl-30797492
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Carcinoma Pulmonar de Células não Pequenas / Desoxicitidina / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Carcinoma Pulmonar de Células não Pequenas / Desoxicitidina / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article